FRET PROTEASE ASSAYS FOR BOTULINUM SEROTYPE A/E TOXINS

Details for Australian Patent Application No. 2002329859 (hide)

Owner ALLERGAN, INC.

Inventors AOKI, Kei, Roger; STEWARD, Lance, E.; FERNANDEZ-SALAS, Ester

Pub. Number AU-A-2002329859

PCT Number PCT/US02/27145

PCT Pub. Number WO2003/020948

Priority 09/942,024 28.08.01 US

Filing date 22 August 2002

Wipo publication date 18 March 2003

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): 09/942,024 28.08.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-A-2002329859

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002329860-METHOD AND APPARATUS FOR SENSING A WAFER IN A CARRIER

2002329858-GPI-ANCHORED CYTOKINES